|
gptkbp:instanceOf
|
medical condition
|
|
gptkbp:abbreviation
|
gptkb:Hallucinogen_Persisting_Perception_Disorder
|
|
gptkbp:affects
|
quality of life
|
|
gptkbp:associatedWith
|
gptkb:MDMA
cannabis
psilocybin
LSD
mescaline
|
|
gptkbp:canBe
|
episodic
chronic
|
|
gptkbp:causedBy
|
withdrawal
acute intoxication
use of hallucinogenic drugs
|
|
gptkbp:characterizedBy
|
gptkb:visual_snow
afterimages
flashbacks
visual disturbances
halos around objects
trailing images
geometric hallucinations
intensified colors
|
|
gptkbp:class
|
mental disorder
|
|
gptkbp:diagnosedBy
|
gptkb:DSM-5_criteria
clinical evaluation
|
|
gptkbp:differentialDiagnosis
|
gptkb:migraine_with_aura
gptkb:visual_snow_syndrome
epilepsy
schizophrenia
|
|
gptkbp:fieldOfStudy
|
neurology
psychiatry
|
|
gptkbp:firstDescribed
|
1954
|
|
gptkbp:fullName
|
gptkb:Hallucinogen_Persisting_Perception_Disorder
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
HPPD
|
|
gptkbp:ICD-10_code
|
F16.983
|
|
gptkbp:includedIn
|
gptkb:DSM-5
|
|
gptkbp:mayInclude
|
anxiety
difficulty concentrating
depersonalization
derealization
|
|
gptkbp:prevalence
|
rare
|
|
gptkbp:riskFactor
|
pre-existing mental health conditions
repeated hallucinogen use
|
|
gptkbp:symptomDuration
|
persistent
|
|
gptkbp:treatment
|
gptkb:psychotherapy
gptkb:benzodiazepines
anticonvulsants
|
|
gptkbp:bfsParent
|
gptkb:hallucinogen_persisting_perception_disorder
|
|
gptkbp:bfsLayer
|
6
|